Fluidic Sciences Ltd services

Fluidic Sciences Ltd. offers the Fluidity One-M instrument, integrated with Microfluidic Diffusional Sizing (MDS) technology, specifically engineered for in-solution analysis of antibodies and their targets throughout various stages of development. The device is designed to ensure stability optimization, target specificity, and modulation of immune responses necessary for therapeutic antibodies, which are widely used in oncology, neurology, and immunology. This instrument's capabilities include the measurement of antibody size changes, affinity assessments, and competition experiments to study ternary complexes. It accommodates diverse sample types, including buffers, serum, and lysates, making it adaptable to various stages of drug formulation and biofluid analysis. Accompanied by the Fluidity Insight smart assistant, guided by advanced machine learning, it assures precise guidance during experimental procedures to deliver robust data consistently. This technology is crucial for the effective analysis of monoclonal and bispecific antibodies' interactions with epitopes in real-world environments.